Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.
about
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerSfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signalingTumor Heterogeneity in Hepatocellular Carcinoma: Facing the ChallengesMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsImpact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinomaEffects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cellsClonal origin of multifocal hepatocellular carcinoma.Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinomaGenetic and epigenetic characteristics of human multiple hepatocellular carcinoma.Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignanciesThe role of secreted frizzled-related protein 2 expression in prostate cancer.Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinomaAn integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.DNA markers in molecular diagnostics for hepatocellular carcinoma.Genome-wide DNA methylation profiles in hepatocellular carcinoma.Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.Expression of SOCS-1 in the liver tissues of chronic hepatitis B and its clinical significance.Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis.Current progress in epigenetic research for hepatocarcinomagenesis.Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.Management of hepatocellular carcinoma should consider both tumor factors and background liver factors.Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma.Role of SOCS1 in tumor progression and therapeutic application.Evaluating DAPK as a therapeutic target.Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma.Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinomaEpigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics.Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinomaIdentification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.Detecting abnormal methylation of tumor suppressor genes GSTP1, P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical significance.Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-Analysis.Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation.Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma.Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.
P2860
Q21245721-E66B50D9-127D-4F83-A5AC-E889838082ADQ24311745-D0BA7334-ED59-45E1-9E73-174CE8FBB111Q26744100-86706A70-F4DA-489C-B470-F1C4554AE6FCQ28383646-533F36DF-FAFB-4629-8329-41A118EE020EQ28730441-BA960F08-4BFF-4021-86E3-7184270C73BAQ33593796-C2E67BB2-B8EC-41F0-BD1B-CD1EEF9B827BQ33610269-923E2402-51D2-46D1-ADF9-4119D595DC3AQ33632373-D91C2BF7-2DD3-4864-9674-D4EF0FA2BF91Q33711037-76E4A058-3749-4AAF-8263-21F82EC6AED6Q33907989-CBEFC055-F502-48DE-91CE-DC830F61820FQ34103775-46CD6969-D266-44B7-A49D-462A5096332BQ34168643-63C2617A-B300-4866-A0FF-7AAA5432C2BBQ34462989-7899AAD3-F403-4227-8CB6-F1A7451C7AD6Q34497012-371F9B76-BA64-45EC-979C-DD101AF5A13DQ35368917-C53163DF-DFEF-4AE3-95A2-146340CFF43DQ35781255-3E67C0BE-C199-469C-839F-8DF6A51621CDQ35899166-EB46CE2D-9928-4808-8CB4-9C0BAD72B1CCQ36450465-CA7636D9-9AE1-4603-AD2B-E09B99285C57Q37189619-8552BF01-6EAC-4FC5-8179-98F24D5E25C8Q37358165-4416D392-3617-4C43-BEDE-7199A94EA249Q37371733-7DDA1CEF-D59E-43F8-8E0F-10143B69C4E4Q37407115-C6E21A26-C696-4E0E-99DE-A0AC544DB5C8Q37582227-875C1E0B-7C4B-4A1C-A531-FCE73981AE6AQ37722925-E1967E3F-A916-4E2C-9FBD-219B2DB956BAQ37843945-65BF44BC-538A-498C-AA79-5F88C43B9877Q37949289-5FCA5315-CCFD-4367-A612-7FFE03AD5D78Q38168688-EB3D8F00-2F0E-45DD-9087-F8B5AB08CC62Q38231065-9E3F817B-302B-4DF4-AD40-89A2B0312F56Q38585070-AB139FFE-EBDD-46B4-939D-D190322E7392Q38857804-AB63F4DA-65A3-4C71-9010-F49AA2D98368Q39027000-EB83B38D-10FB-44BA-A318-D9B7E4E6DDDFQ39739609-52924D0E-A1C5-4131-B292-26397271706EQ40257588-525834B9-4028-4C8E-9BF2-537D3EC023D0Q41369277-11D94C9E-2FAD-4379-9C73-CBDDA117562CQ41460442-EF137E1D-D0B3-4FE9-9222-36F982B74E6BQ42233205-0E0AA5F3-0461-4505-94B7-F22CB98183A1Q42610253-501E9004-CEFD-45CA-AAAF-DA55F7516A8FQ42695141-A5931AF0-B1AC-4D36-92F4-FBAF1B1E51BBQ53085477-78085BDE-1E3A-4298-89E6-F99B03828E6BQ53281416-C82B520E-357A-48B4-AB65-F2266FBCA84D
P2860
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hypermethylation of multiple g ...... tric hepatocellular carcinoma.
@ast
Hypermethylation of multiple g ...... tric hepatocellular carcinoma.
@en
type
label
Hypermethylation of multiple g ...... tric hepatocellular carcinoma.
@ast
Hypermethylation of multiple g ...... tric hepatocellular carcinoma.
@en
prefLabel
Hypermethylation of multiple g ...... tric hepatocellular carcinoma.
@ast
Hypermethylation of multiple g ...... tric hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Hypermethylation of multiple g ...... tric hepatocellular carcinoma.
@en
P2093
H Sugimoto
N Kanazumi
T Kinoshita
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604016
P407
P577
2007-10-30T00:00:00Z